Received Nov 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | IM / LA |
Shingles; This non-serious case was reported by a consumer via call center representative and described the occurrence of shingles in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 12-AUG-2025, the patient received the 1st dose of Shingrix (intramuscular, left arm) .5 ml. On 24-OCT-2025, 73 days after receiving Shingrix, the patient experienced shingles (Verbatim: Shingles). The patient was treated with prednisone acetate (Prednisone). The outcome of the shingles was not resolved. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date: 27-OCT-2025 The reporter was the patient. She reports that she received the 1st dose of Shingrix vaccine. The reporter enquiring did the vaccine cause to get shingles, should get the 2nd dose. The patient have 2 small lumps in the left eye lid that are swollen and burning. She went to the health care professional and was prescribed Prednisone and an anti-viral medication that starts with the letter G, (unknown name). The patient reports it was starting to happen on the right eye also. She reports having the same symptoms on the right eye. No additional information was provided. The batch number was not provided and a request for this information has been made.